Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review
- PMID: 38854273
- PMCID: PMC11162198
- DOI: 10.7759/cureus.59975
Causality, Severity, Preventability and Predictability Assessments Scales for Adverse Drug Reactions: A Review
Abstract
The pharmacovigilance program of India (PvPI), after its inception, has been reliably acquiring force in bringing issues to light among the masses, healthcare professionals, the pharma industry, and clinical staff at hospitals. Adverse drug reactions are unintended events that occur after exposure to a drug, biological product, or medical device, and they may result in morbidity and mortality. It is critical to monitor the safety of drugs during the post-marketing phase to find long-term and rare ADRs, as well as ADRs in special populations and patients with co-morbidities that are not usually included during clinical trials. The definitive objective of pharmacovigilance is to collate data and analyze it. Assessing the causality between ADRs and drugs is necessary to decrease the occurrence of ADRs and to reduce the risk of drug-related ADRs. ADRs may lead to increased morbidity, increased hospital stays, and increased cost of treatment, resulting in compromised patient safety. Causality assessment is the evaluation of the likelihood that a particular treatment is the cause of an observed adverse event and establishing a causal association between a drug and a drug reaction is necessary to prevent further recurrences. Numerous methods available for establishing a causal association between the drug and adverse events have been broadly classified into clinical judgment or global introspection, algorithms, and probabilistic methods. These include the Swedish method, World Health Organization-Uppsala Monitoring Centre (WHO-UMC) scale, Naranjo's algorithm, Kramer algorithm, Jones algorithm, Karch algorithm, Bégaud algorithm, Adverse Drug Reactions Advisory Committee guidelines, Bayesian Adverse Reaction Diagnostic Instrument, and so on. Despite various methods available, none of the causality assessment tools have been universally accepted as the gold standard. Naranjo's algorithm and WHO-UMC scales are, however, the most commonly used. Similarly, for preventability and severity assessment of ADRs, the Schumock and Thornton scale and Hartwig and Siegel's scale are most commonly used. Hence, we reviewed different tools and methods available to assess the causality, preventability, and severity of ADRs.
Keywords: adverse drug reaction reporting; causality assessment; pharmacovigilance; preventability assessment; severity assessment.
Copyright © 2024, Manjhi et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital.Indian J Med Res. 2022 Jul;156(1):111-121. doi: 10.4103/ijmr.IJMR_1275_20. Indian J Med Res. 2022. PMID: 36510903 Free PMC article.
-
Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India.Perspect Clin Res. 2015 Apr-Jun;6(2):109-15. doi: 10.4103/2229-3485.154014. Perspect Clin Res. 2015. PMID: 25878957 Free PMC article.
-
A Retrospective Observational Study of Adverse Drug Reactions (ADR) Reported to ADR Monitoring Centre from 2010 to 2020.Curr Drug Saf. 2025;20(3):349-360. doi: 10.2174/0115748863317987241015034413. Curr Drug Saf. 2025. PMID: 39440781
-
Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings.J Appl Biomed. 2023 Jun;21(2):59-66. doi: 10.32725/jab.2023.010. Epub 2023 Jun 21. J Appl Biomed. 2023. PMID: 37376882 Review.
-
Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India.Indian J Pharmacol. 2021 Mar-Apr;53(2):143-152. doi: 10.4103/ijp.ijp_901_20. Indian J Pharmacol. 2021. PMID: 34100398 Free PMC article. Review.
Cited by
-
Adverse Drug Reactions in an Intensive Care Unit of a Secondary Care Lithuanian Hospital: A Prospective Observational Study.Healthcare (Basel). 2025 Jul 3;13(13):1592. doi: 10.3390/healthcare13131592. Healthcare (Basel). 2025. PMID: 40648617 Free PMC article.
-
Skin-Related Adverse Reactions Induced by Oral Antidiabetic Drugs-A Review of Literature and Case Reports.Pharmaceuticals (Basel). 2024 Jun 27;17(7):847. doi: 10.3390/ph17070847. Pharmaceuticals (Basel). 2024. PMID: 39065698 Free PMC article. Review.
-
The Long-Term Cardiovascular Risks of Duloxetine Use in Older Adults: A Retrospective Medical Record-Based Adverse Drug Reaction Assessment.J Clin Med. 2024 Dec 13;13(24):7595. doi: 10.3390/jcm13247595. J Clin Med. 2024. PMID: 39768518 Free PMC article.
-
The Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Acute Cholecystitis After a Routine Colonoscopy: A Case Report.Cureus. 2025 Feb 16;17(2):e79105. doi: 10.7759/cureus.79105. eCollection 2025 Feb. Cureus. 2025. PMID: 40104488 Free PMC article.
-
Risk factors for severe adverse drug reactions in hospitalized patients.Open Med (Wars). 2025 Jan 13;20(1):20241122. doi: 10.1515/med-2024-1122. eCollection 2025. Open Med (Wars). 2025. PMID: 39822991 Free PMC article.
References
-
- Pharmacovigilance guidance document for marketing authorization holders of pharmaceutical products. [ Jun; 2022 ]. 2018. https://www.ipc.gov.in/PvPI/pub/Guidance%20Document%20for%20Marketing%20... https://www.ipc.gov.in/PvPI/pub/Guidance%20Document%20for%20Marketing%20...
-
- Therapeutic effect of urapidil on myocardial perfusion in patients with ST-elevation acute coronary syndrome. Yao DK, Jia SQ, Wang L, Li HW, Zhang YC, Wang YL, Wang LX. Eur J Intern Med. 2009;20:152–157. - PubMed
-
- Under-reporting of adverse drug reactions : a systematic review. Hazell L, Shakir SA. Drug Saf. 2006;29:385–396. - PubMed
-
- Combination therapy with fluconazole and other QTc-prolonging drugs increase the QTc interval (Article in Danish) Buch T, Andersen SE. https://pubmed.ncbi.nlm.nih.gov/26471025/ Ugeskr Laeger. 2015;177:0. - PubMed
Publication types
LinkOut - more resources
Full Text Sources